Priya Prasad: How Frequent Blood Donors Can Prevent Hidden Iron Deficiency
Priya Prasad, Senior Specialist at Caritas Hospital, shared a post on LinkedIn:
“‘My haemoglobin is normal, Doctor. So I don’t have iron deficiency.’
Not always!
One of the most important things we can teach our blood donors is that haemoglobin and iron stores are not the same thing.
What happens to iron when we donate blood?
A standard whole-blood donation removes approximately 450 mL of blood and around 200–250 mg of iron along with the red blood cells.
The donated plasma volume is replaced relatively quickly.
Red-cell mass and haemoglobin take longer to recover.
But the bigger issue is that iron stores may take considerably longer to replenish.
And repeated donations can progressively reduce those stores.
Therefore, a donor can have:
- Acceptable haemoglobin
- Low ferritin / depleted iron stores
Even before overt iron-deficiency anaemia develops.
This is why relying on haemoglobin alone may not identify every donor who is becoming iron depleted.
Who is particularly vulnerable?
Iron depletion deserves particular attention in:
- Frequent blood donors
- Menstruating women
- Women with heavy menstrual bleeding
- Younger donors
- Donors with low dietary iron intake
- Donors with a previous history of iron deficiency
Does this mean we should discourage blood donation?
Absolutely not!
Voluntary blood donation remains one of the most valuable contributions an individual can make to healthcare.
A message for donors:
If you are a frequent donor – particularly if you are a menstruating woman , talk to your healthcare professional about whether your iron stores may need assessment.
And a message for transfusion professionals:
Our responsibility does not end when the blood bag is labelled and stored.
The donor is also someone whose health we are responsible for protecting.”
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 16, 2026, 13:05Maha Othman: Queen’s Health Sciences Advances CAT Risk Models and Pediatric ISTH-BAT Cut-Offs
-
Oct 16, 2026, 13:03Thrombosis Awareness Must Lead to Timely Action – Roche
-
Oct 16, 2026, 12:49Wolfgang Miesbach: 5-Year CBDR Data Confirms Emicizumab Safety and Efficacy in Hemophilia A
-
Oct 16, 2026, 12:40Edward Lee Carter: How Factor XI Inhibition Could Transform Anticoagulation Therapy
-
Oct 16, 2026, 12:40Marc Carrier: Looking Ahead to ISTH 2027 in Vancouver
-
Oct 16, 2026, 12:30Bob Lempke: How One Blood Donation Can Save Up to Three Lives
-
Oct 16, 2026, 12:30Why VWF Therapies Belong on the EU Critical Medicines List – EHC
-
Oct 16, 2026, 12:17Exploring Endothelial Cells, Genetic Fate Mapping, and Revascularization – ISTH
-
Oct 16, 2026, 10:07Habib Bennaceur: Building a Stronger Care Pathway for Sickle Cell Disease in India